A case study of a clinical pharmacist's involvement in immune-associated pneumonia and myocarditis caused by pembrolizumab in a patient with ovarian cancer
Objective To analyse the clinical characteristics,occurrence mechanism,diagnosis and treatment plan of one case of pablizumab induced immune-associated pneumonia and myocarditis.Methods Clinical pharmacists searched the relevant literature to summarize the clinical characteristics,occurrence mechanism of pablizumab induced immune-associated pneumonia and myocarditis,and assisted in diagnosis and treatment.Results After active treatment,the patient's regression was better.Conclusion The clinical pharmacists graded the adverse effects by referring to the guidelines for immunotoxicity management,and therapeutic recommendations were given,which resulted in a better regression,reflecting the value of the services provided by clinical pharmacists.
Platinum-resistant ovarian cancerImmune-associated pneumoniaImmune-associated myocarditisCase study
万方数据
维普
